首页制药产品大全药品制剂心脑血管及循环系统类制剂 Captopril

Captopril

更新时间：2026-02-27

价格： 7 元/个

地区：上海市

是否提供样品：否

立即询盘

产品详情

产品名称： Captopril

产品分类：心脑血管及循环系统类制剂

产品关键词： ACE Inhibitor,Hypertension Management,Heart Failure Treatment,Renal Protection

是否为生产商：是

产品包装规格： 25mg/table 10*10tables/box

主要销售市场：中国,北美洲,中/南美洲,西欧,大洋洲,亚洲,中东

是否提供样品：否

产品描述：

Mechanism of Action

Captopril is an angiotensin-converting enzyme (ACE) inhibitor that works by blocking the conversion of angiotensin I to angiotensin II. This inhibition leads to vasodilation, reduced blood pressure, and decreased aldosterone secretion, which helps in lowering blood pressure and improving cardiac output. It also increases levels of bradykinin, a peptide that causes vasodilation, which may contribute to its therapeutic effects.

Dosage and Administration

Adults:Hypertension: Initial dose is 25 mg two or three times daily, taken one hour before meals. The dose may be increased to 50 mg two or three times daily after one or two weeks if blood pressure is not adequately controlled.Heart Failure: Initial dose is 25 mg three times daily, typically in combination with a diuretic and digitalis. The dose may be increased to 50 mg three times daily after two weeks.Post-Myocardial Infarction: Initial dose is 6.25 mg three times daily, starting three days after a heart attack. The dose may be increased to 12.5 mg and then to 25 mg three times daily over several days.
Children: Dosage is not established for children.
Administration Notes:
Take Captopril on an empty stomach, one hour before or two hours after a meal, to ensure optimal absorption.
Monitor blood pressure, electrolyte levels, and renal function regularly, especially during the initial treatment period.

Storage

Store Captopril at room temperature, between 68°F to 77°F (20°C to 25°C). It can be exposed to temperatures between 59°F to 86°F (15°C to 30°C) for short periods, such as during transportation. Keep the container tightly closed, in a cool, dry place, and protect from light and moisture.

Currently, we are sourcing the distributors or agents all around the world.

Please do not hesitate to contact us immediately if you are interested in this product.

Looking forward to strong cooperation with you in the near future!

Brief Introduction to Our Company:
Shandong Sino Pharmaceutical Technology Co., Ltd. (S.S.P.T.) is a different kind of pharmaceuticals (both finished medicine products and raw materials), health products, cosmetics and medical supplies company for human needs, focusing on global markets, especially the developing world. Working with the highest levels of government and local distributors alike, we aim to not only expand our business scale and scope but also have a special interest in serving the needs of the end consumer that requires our products the most. To this end, we have a presence in 5 continents with an expanding product range to meet the demand of our main markets.

Moreover, our manufacturing facilities follow strict GMP rules and regulations. We have intergraded all GMP guidelines into internal procedures improving the degree to which results are consistently exceeding expectations. As one of the best pharmaceutical companies in China, we take our ethical obligation to improving access to high quality and affordable WHO essential drugs seriously. This is the ethical basis our company was founded on.
Consignment Manufacturing, Brand OEM/ODM Service are available.

公司简介

上海浦津林州制药有限公司，始建于1974年，其前身是林州市市属工业企业--安阳市化学制药厂， 2015年9月更名为“上海浦津林州制药有限公司” 公司位于风景秀丽的太行山东麓，举世闻名的人工天河——红旗渠畔，交通便利，通讯发达。公司占地面积5.5万m2，建筑面积1.9万m2，其中仓储面积3000 m2；厂区绿化面积16000 m2，硬化面积8000 m2。现有职工300余人，固定资产总值6418万元，主导产品主要有葡萄糖酸钙、硫酸镁、维生素C、肌苷等35个注射液品种，在市场上深受广大客户青睐，市场前景广阔。公司为了进一步扩大生产规模，提升产品档次，提高市场占有率，先后投资3.6亿余元，进行技术改造，现在拥有12条符合国家GMP标准的小容量注射剂全自动生产线，并于2014年5月通过国家食品药品监督管理局GMP认证；新建车间年设计生产能力12亿支，可实现产值3亿多元，利税5000余万元。近年来，公司创新意识不断增强，始终把“技术创新，科技兴厂”作为公司发展的宗旨，企业发展空间大、前景广阔，愿各界同仁、有识之士携手并进，共谋美好未来。

该公司其他产品

Insulin Pen: Precision and Convenience for Diabetes Management

Mechanism of ActionInsulin pens are designed to deliver insulin directly into the subcutaneous tissue. They combine the insulin cartridge and a syringe into a single, portable device. The pen allows for precise dosing and administration, ensuring that the exact amount of insulin is delivered each time. This mechanism helps in better glucose control by providing accurate and consistent insulin doses.BenefitsConvenience: Insulin pens are compact, portable, and easy to use, making them ideal for on-the-go insulin administration.Accuracy: They offer precise dosage adjustments, reducing the risk of dosing errors compared to traditional syringes and vials.Discreetness: The design allows for discreet use in public settings.Reduced Pain: Insulin pens typically use fine needles, resulting in less pain and discomfort during injections.Improved Compliance: The ease of use and accuracy can enhance patient adherence to their insulin regimen.Usage InstructionsPreparation: Wash your hands thoroughly. Attach a new pen needle to the insulin pen.Priming: Prime the pen by dialing a small dose and expelling it into the air until a droplet forms at the needle tip. This step ensures there are no air bubbles in the pen.Dose Selection: Dial the prescribed insulin dose using the pen’s dose selector.Injection: Pinch the skin at the injection site (commonly the abdomen or thigh) and insert the needle at a 90-degree angle. Press the plunger fully to administer the insulin.Post-Injection: Remove the needle and dispose of it safely. Recap the pen for storage.StorageUnopened Pens: Store insulin pens in the refrigerator at 2°C to 8°C (36°F to 46°F) until they are ready to be used.Opened Pens: Once started, pens can be stored at room temperature (not exceeding 30°C/86°F) for up to 28 days.Protection from Temperature Extremes: Avoid exposing the pen to extreme temperatures, as this can damage the insulin.

Artemether: Potent Antimalarial for Malaria Management

Mechanism of ActionArtemether is a derivative of artemisinin, a natural compound derived from the plant Artemisia annua. It exerts its antimalarial effects primarily through the following mechanisms:Generation of Free Radicals: Artemether contains an endoperoxide bridge that is cleaved in the presence of heme (a byproduct of hemoglobin digestion by the malaria parasite). This process generates highly reactive free radicals, which damage the parasite's cell membranes and disrupt its essential cellular functions.Inhibition of Parasite Enzymes: Artemether inhibits an essential calcium ATPase (PfATP6) in the malaria parasite, leading to intracellular calcium accumulation and subsequent cell death.Disruption of Hemoglobin Detoxification: Artemether interferes with the parasite's ability to detoxify heme, which is produced during hemoglobin digestion. This leads to the accumulation of toxic substances within the parasite, ultimately causing its death.Inhibition of Nucleic Acid and Protein Synthesis: Artemether and its active metabolite, dihydroartemisinin, inhibit the synthesis of nucleic acids and proteins in the malaria parasite, further contributing to its antimalarial activity.ApplicationsArtemether is primarily used for the treatment of malaria caused by Plasmodium falciparum, including:Uncomplicated Malaria: Artemether is effective against uncomplicated malaria infections, particularly in regions where chloroquine resistance is prevalent.Severe Malaria: Although artemether can be used for severe malaria, intramuscular artemether is less reliable than other artemisinin derivatives like artesunate due to its poor water solubility and variable absorption.Multidrug-Resistant Malaria: Artemether is often used in combination with other antimalarial drugs (e.g., lumefantrine) to treat malaria that is resistant to multiple drugs.Dosage and AdministrationAdults:Oral/Intramuscular: 80 mg twice daily on the first day, followed by 80 mg once daily for the next 4 days. The maximum total dose is 480 mg over 5 days.Children:Intramuscular: 3.2 mg/kg body weight on the first day, followed by 1.6 mg/kg once daily for the next 4 days. The maximum total dose is 9.6 mg/kg over 5 days.Combination Therapy: When used in combination with lumefantrine, the dosing schedule may vary depending on the specific formulation and patient weight.Example for Artemether-Lumefantrine Combination:Children (5-15 kg): 1 tablet at diagnosis, 1 tablet after 8 hours, then 1 tablet twice daily for the next 2 days.Children (15-25 kg): 2 tablets at diagnosis, 2 tablets after 8 hours, then 2 tablets twice daily for the next 2 days.Adults and Children (≥35 kg): 4 tablets at diagnosis, 4 tablets after 8 hours, then 4 tablets twice daily for the next 2 days.StorageConditions: Artemether should be stored in a cool, dry place, protected from light and moisture. It is typically stable at room temperature (15-30°C) but should be kept out of reach of children.Expiration: Always check the expiration date on the product packaging. Do not use expired medication.

Furosemide : Effective Loop Diuretic for Heart Failure and Hypertension

Mechanism of ActionFurosemide is a potent loop diuretic that primarily works by inhibiting the Na+/K+/2Cl⁻ co-transporter (NKCC2) in the thick ascending limb of the loop of Henle in the kidneys. By blocking this transporter, furosemide reduces the reabsorption of sodium, potassium, and chloride ions. This leads to an increase in the osmolarity of the tubular fluid, resulting in greater water retention in the renal tubules and ultimately increased urine output. Additionally, furosemide can increase the synthesis of prostaglandin E2 (PGE2), which helps to dilate renal blood vessels, enhance renal blood flow, and increase glomerular filtration rate.ApplicationsEdema Management: Furosemide is used to treat edema associated with various conditions such as heart failure, cirrhosis (e.g., ascites), and nephrotic syndrome.Hypertension Management: It reduces blood pressure by decreasing blood volume through diuresis.Acute Pulmonary Edema: Furosemide can rapidly alleviate symptoms of acute pulmonary edema.Hyperkalemia: It helps lower serum potassium levels by promoting potassium excretion.Dosage and AdministrationOral Administration:Adults: The initial dose is typically 20–80 mg once or twice daily.Children: The dose is usually calculated based on body weight, at 1–2 mg/kg once or twice daily.Onset of Action: Oral administration typically results in diuresis within 30–60 minutes, with peak effects occurring within 1–2 hours.Duration of Action: The diuretic effect lasts for approximately 6–8 hours.Intravenous (IV) Administration:Adults: The initial dose is usually 20–40 mg, which may be repeated if necessary.Children: The dose is 1–2 mg/kg, which may be repeated if necessary.Onset of Action: IV administration results in diuresis within 5 minutes, with peak effects occurring within 30 minutes.Duration of Action: The diuretic effect lasts for approximately 2 hours.Precautions: When using furosemide, it is essential to closely monitor electrolyte levels to avoid electrolyte disturbances caused by excessive diuresis.StorageStorage Conditions: Furosemide tablets should be stored in a dry, cool place, protected from high temperatures and direct sunlight.Expiration Date: Always refer to the expiration date on the product packaging. Do not use expired medication.Child Safety: Ensure that the medication is stored out of reach of children.

产品名称	价格	供应商	操作
Cap A	面议	天津市康科德科技有限公司	立即询盘
Capecitabine	面议	上海微巨实业有限公司	立即询盘
CAPECITABINE	面议	杭州赛洛化工贸易有限公司	立即询盘
Capecitabine	面议	杭州华镕医药有限公司	立即询盘
Capecitabine	面议	无锡金丽洁国际贸易有限公司	立即询盘
Capecitabine	面议	南京润楚化工有限公司	立即询盘
Capecitabine	100元	苏州科途生物技术有限公司	立即询盘
Capecitabine	面议	上海一诚医药科技有限公司	立即询盘
Capecitabine	面议	雅本化学股份有限公司	立即询盘
Capecitabine Impurity 10	来电咨询	深圳市祥根医药有限公司	立即询盘

上海浦津林州制药有限公司

Years

访问商铺

注册资本

联系人林飞

查看联系方式